Does Combination Therapy with Desmopressin and Tolterodine Improve the Treatment Outcomes of Patients with Monosymptomatic Nocturnal Enuresis? A Randomized Clinical Controlled Trial

Table 1

Age and gender of patients.

Variable	Group		𝑃 value
	Desmopressin + Tolterodine	Desmopressin + placebo
Age (mean)	9.26 ± 1.85	9.50 ± 1.68	0.547
Gender	50% male, 48% female	42% male, 58% female	0.414